: Portal flow modulation by Spleen Artery Ligation to Prevent Post-Hepatectomy Liver Failure: A randomized control trial
Phase 2
- Conditions
- Patient who underwent open hepatectomyPostoperative hepatectomy failure, splenic artery ligation, PHLF, SALPostoperative hepatectomy failure, splenic artery ligation, PHLF, SA
- Registration Number
- TCTR20210527003
- Lead Sponsor
- Faculty of Medicine CM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
1. Patient who underwent hepatectomy (at least 2 segments) with and without bile duct resection
Hepatocellular carcinoma
Cholangiocarcinoma
Colorectal liver metastasis
Benign liver tumor
Cystic tumor of liver
Liver abscess
2. open hepatectomy
3. Age 20-70 year
4. accept to join this program
Exclusion Criteria
Patients who is unresectable by surgical technique reason
Metastasis liver disease
High risk for surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-hepatic liver failure post op day 0 1 3 5 after end of the intervention, 3 month after surgery ISGLS definition
- Secondary Outcome Measures
Name Time Method Ascites until off drain Drain,Death rate 3 month survival,post operative complication until discharge infection, SSI, reintubation